IMTX
(NASDAQ)Immatics N.V.
$9.29-- (--)
Loading... - Market loading
Immatics (IMTX) Stock Price & Financial Analysis
Immatics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$9.00 - $9.41
52-Week High$12.41
52-Week Low$5.05
Open$9.02
Volume352.46K
Average Volume (3M)360.94K
Market Cap1.23B
Shares Outstanding134.64M
Price to Sales (P/S)29.67
Price to Book (P/B)2.43
EV/EBITDA-4.46
Revenue (TTM)42.46M
Net Income (TTM)-244.56M
Free Cash Flow (TTM)-215.59M
EPS (TTM)$-1.94
Profit Margin-574.86%
Operating Margin-570.30%
Return on Equity (ROE)-46.99%
Debt to Equity0.04
50-Day MA$10.21
200-Day MA$10.12
52-Week Change51.37%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$9.00 - $9.41
52-Week High$12.41
52-Week Low$5.05
Open$9.02
Volume352.46K
Average Volume (3M)360.94K
Market Cap1.23B
Shares Outstanding134.64M
Price to Sales (P/S)29.67
Price to Book (P/B)2.43
EV/EBITDA-4.46
Revenue (TTM)42.46M
Net Income (TTM)-244.56M
Free Cash Flow (TTM)-215.59M
EPS (TTM)$-1.94
Profit Margin-574.86%
Operating Margin-570.30%
Return on Equity (ROE)-46.99%
Debt to Equity0.04
50-Day MA$10.21
200-Day MA$10.12
52-Week Change51.37%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Immatics
What is the current stock price for IMTX?
As of the latest trading session, IMTX stock trades at $9.29. The 52-week range is $5.05–$12.41, with a day range of $9.00–$9.41.
What is the P/E ratio for IMTX?
The P/E ratio (Price-to-Earnings) for IMTX is shown in the Key Statistics section. This valuation metric helps compare Immatics N.V. to industry peers.
Does IMTX pay dividends?
Immatics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMTX?
Based on 6 analysts, the consensus for IMTX is Buy.
What is the market cap of IMTX?
Immatics's market capitalization is $1.25B, classifying it as a small-cap company. Immatics operates in the Healthcare sector within the Biotechnology industry.